AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metglib MF 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Taurus Laboratories Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Metglib MF 1mg/500mg Tablet

Glimepiride/Metformin 1mg/500mg tablets are classified as antidiabetic medications. This dual-drug formulation treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; premature discontinuation, without medical supervision, risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan, incorporating a healthy diet, regular physical activity, and weight management as recommended by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Maintain regular mealtimes and carry readily available glucose sources, such as sugary snacks or juice, to counteract this. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalgia, and upper respiratory infections. Weight gain is a possibility. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your doctor before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.

Primary Ingredients of Metglib MF 1mg/500mg Tablet

There is no text provided to rephrase.

Uses of Metglib MF 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Metglib MF 1mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Metglib MF 1mg/500mg Tablet should be administered with a meal.

Common Side effects of Metglib MF 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Metglib MF 1mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Metglib MF 1mg/500mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Metglib MF 1mg/500mg Tablet works:

Glimepiride and Metformin, combined as Metglib MF 1mg/500mg tablets, offer a dual approach to diabetes management. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Metglib MF 1mg/500mg tablets with alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Metglib MF 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Always seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Metglib MF 1mg/500mg tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Metglib MF 1mg/500mg tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Metglib MF 1mg/500mg tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Metglib MF 1mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should involve a low dose; the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Metglib MF 1mg/500mg Tablet :

Should you forget a dose of Metglib MF 1mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metglib MF 1mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Metglib MF 1mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Metglib MF 1mg/500mg Tablets can cause lactic acidosis, a serious, potentially life-threatening condition involving excessive blood lactic acid (also known as MALA—Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Metglib MF 1mg/500mg Tablets and seek immediate medical attention.
Metglib MF 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Metglib MF 1mg/500mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Metglib MF 1mg/500mg Tablet use can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues like numbness and tingling in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental Vitamin B12 intake is recommended by some researchers.
Metglib MF 1mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Metglib MF 1mg/500mg Tablet and alcohol is unsafe. This combination can lower blood sugar, potentially causing hypoglycemia, and increase the risk of lactic acidosis.
Metglib MF 1mg/500mg Tabl...
22
MRP 25
12% off